Wednesday, November 4, 2020
Program Agenda

8:00 AM BioCalm: Mindful Meditation

8:30 AM Break

9:00 AM Concurrent Sessions

TRACK A – COVID IN 2021 & BEYOND
Future-Proofing Your Lab: Flexible and Adaptable Designs for Rapidly Changing and Uncertain Environments

TRACK B – CRO & CMO
Buyer Beware: Common (and Commonly Hidden) Costs in Preclinical Research

TRACK C – BIOPHARMACEUTICALS & DRUGS
Litigation Minefields: The Importance of Risk Management

TRACK D – COMMUNITY & ECOSYSTEM
Racial Inequality in Healthcare

9:50 AM Break

10:00 AM Opening & Keynote

Opening & State of the Industry
Maria Thacker-Goethe, President & CEO, Georgia Bio
Steve Gertz, Co-Founder, Chief Development Officer, 11|Ten Innovation Partners

Summit Chair Remarks & Keynote Intro
Everett Hoekstra, President, Boehringer Ingelheim Animal Health USA Inc.

Keynote Address: "Opportunities and Challenges for Science and Innovation in 2021"
Dr. Michelle McMurry-Heath, President & CEO, Biotechnology Innovation Organization (BIO)

11:00 AM Break

11:10 AM Concurrent Sessions

TRACK A – COVID IN 2021 & BEYOND
One Health: Collaborative Approach to Ensuring Human, Animal and Ecosystem Health

TRACK B – CRO & CMO
Continuation of Clinical Research Study Activities

TRACK C – BIOPHARMACEUTICALS & DRUGS
The Journey & Impact of Innovation Translation

TRACK D – COMMUNITY & ECOSYSTEM
Staffing & Talent Plan: Building Your Team to Hit Each Milestone

12:00 PM Exhibit Hall

12:30 PM Keynote

Keynote Address: “Collaboration in the COVID Crisis: How Unprecedented Partnerships are Accelerating Successful Vaccines & Therapeutics”
• Dr. Paul Burton, Chief Global Medical Affairs Officer, Janssen Pharmaceuticals
• Dr. Alejandro Cané, Chief Patient Officer, Pfizer
• Dr. Clement Lewis, Associate Vice President Head BARDA Office & NV Stakeholder Engagement, Sanofi Pasteur

1:30 PM PitchRound

2:00 PM Company Showcase

Show More

 

SPONSORS

© 2020 by Georgia Bio. 

#GaBioSummit

GEORGIA BIO INNOVATION SUMMITLogo_Color.png